Bulk Manufacturer of Controlled Substances Registration, 53106-53107 [2018-22829]
Download as PDF
<![CDATA[
53106
Federal Register / Vol. 83, No. 203 / Friday, October 19, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
the public interest in this investigation,
as appropriate, and provide the
Commission with findings of fact and a
recommended determination on this
issue, which shall be limited to the
statutory public interest factors set forth
in 19 U.S.C. 1337(d)(1), (f)(1), (g)(1);
(4) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
INVT SPE LLC, One Market Plaza, Spear
Tower, 42nd Floor, San Francisco, CA
94105.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Apple Inc., 1 Infinite Loop, Cupertino,
CA 95014.
HTC Corporation, 23 Xinghua Road,
Taoyuan City, Taoyuan County 330,
Taiwan.
HTC America, Inc., 308 Occidental Ave.
S, Suite 300, Seattle, WA 98104.
ZTE Corporation, ZTE Plaza, Keji Road
South, Hi-Tech Industrial Park,
Nanshan District, Guangdong
Province, 518057, China.
ZTE (USA) Inc., 2425 N Central
Expressway, Suite 800, Richardson,
TX 75080.
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(5) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: October 16, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–22869 Filed 10–18–18; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Consortium for Execution
of Rendezvous and Servicing
Operations
Notice is hereby given that, on
September 10, 2018, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Consortium for Execution of
Rendezvous and Servicing Operations
(‘‘CONFERS’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: Altius Space Machines,
Inc., Broomfield, CO; Analytical
Graphics, Inc., Exton, PA; Astroscale
PTE. LTD., Tokyo, JAPAN; Ball
Aerospace and Technology Corp.,
Boulder, CO; Chandah Space
Technologies, Houston, TX; Hoffer Flow
Controls, Inc. Elizabeth City, NC; iBOSS
gmbH, Aachen, GERMANY; MacDonald,
Dettwiler and Associates, Inc.,
Brampton, Ontario, CANADA; Thales
Alenia Space, Courbevioe, FRANCE;
The Aerospace Corporation, El Segundo,
CA; and XL Catlin, LLC, New York, NY.
The general area of CONFERS’
planned activity is to establish an
independent, self-sustaining industry
forum to advocate and promote on-orbit
satellite maintenance, servicing, and
rendezvous operations by collaborating
to research, develop, and publish
voluntary, consensus technical and
safety standards, and engaging with
governments on policy and oversight of
satellite servicing activities. To fulfill its
mission, CONFERS will recruit a broad
array of members from satellite
operators, service providers, insurers
and underwriters, and engage other
stakeholders from industry, academia,
and governments. The process will be
fully collaborative and will include
dedicated outreach activities to engage
the global commercial satellite
community. The members of the
CONFERS believe that future standards
should be based on a set of guiding
principles that will help establish
responsible norms of behavior.
Suzanne Morris,
Chief, Premerger and Division Statistics Unit,
Antitrust Division.
[FR Doc. 2018–22826 Filed 10–18–18; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed in the table
below. No comments or objections were
submitted for this notice.
SUMMARY:
Company
FR Docket
Published
Siegfried USA, LLC .................................................................................................................................................
83 FR 32905 ..
July 16, 2018.
VerDate Sep<11>2014
17:25 Oct 18, 2018
Jkt 247001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
E:\FR\FM\19OCN1.SGM
19OCN1
53107
Federal Register / Vol. 83, No. 203 / Friday, October 19, 2018 / Notices
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
Dated: October 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–22829 Filed 10–18–18; 8:45 am]
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices are listed in the table below. No
comments or objections were submitted
and no requests for hearings were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUMMARY:
Notice of registration.
Company
FR Docket
Published
Chattem Chemicals, Inc ..........................................................................................................................................
83 FR 39129 ..
Myoderm .................................................................................................................................................................
83 FR 39130 ..
Mylan Pharmaceuticals, Inc ....................................................................................................................................
Anderson Brecon, Inc .............................................................................................................................................
83 FR 22517 ..
83 FR 39128 ..
August 8,
2018.
August 8,
2018.
May 15, 2018.
August 8,
2018.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: October 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–22830 Filed 10–18–18; 8:45 am]
amozie on DSK3GDR082PROD with NOTICES1
registration as a bulk manufacturer to
the above listed company.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Noramco Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 19, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 19, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearings
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
DATES:
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on July 4,
2018, Noramco Inc., 1550 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Marihuana Extract ...........................................................................................................................................................
VerDate Sep<11>2014
17:25 Oct 18, 2018
Jkt 247001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
E:\FR\FM\19OCN1.SGM
19OCN1
7350
Schedule
I
]]>Agencies
[Federal Register Volume 83, Number 203 (Friday, October 19, 2018)]
[Notices]
[Pages 53106-53107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22829]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as a bulk
manufacturer of various classes of schedule I and II controlled
substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as a bulk manufacturer of various basic classes of
controlled substances. Information on a previously published notice is
listed in the table below. No comments or objections were submitted for
this notice.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Siegfried USA, LLC............ 83 FR 32905........ July 16, 2018.
------------------------------------------------------------------------
[[Page 53107]]
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of this registrant to manufacture the
applicable basic classes of controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed company.
Dated: October 10, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22829 Filed 10-18-18; 8:45 am]
BILLING CODE 4410-09-P
